tirzepatide lily Eli Lilly, Maker of Mounjaro and Zepbound, Wades Into Telehealth Lilly's next-gen obesity drug shows

While these medications are not FDA-branded products like Wegovy or Mounjaro, they are identical in molecular structure and carry the same sharps disposal requirements

Zepbound is a prescription obesity drug containing tirzepatide, manufactured by Eli Lilly and approved for chronic weight management after receiving FDA approval for use in eligible adults with obesity or overweight with certain related conditions

Within authorised clinical trials, storage conditions, in-use stability, and handling requirements for retatrutide are defined by the trial sponsor's protocol and IMP dossier

People with diabetes When semaglutide is used alongside other diabetes medications, particularly insulin or sulfonylureas, the risk of hypoglycemia (low blood sugar) increases